Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
Laurus Labs (LAURUS IN)
Watchlist
65
Analysis
Health Care
•
India
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .
more
Watchlist
All
Insights
Primers
New
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Aarti Drugs Ltd
•
12 Sep 2020 14:27
India Small Caps: Position for Outperformance Vs Large & Mid Caps
Late Friday evening, the Securities and Exchange Board of IndianÂ
Brian Freitas
Follow
694 Views
Share
bullish
•
Laurus Labs
•
16 Nov 2018 20:30
Laurus Labs 2QFY19 Results Update -Â Growth Likely to Begin from FY20E
Laurus Labs (LAURUS IN) disappointed on sales and reported PAT but EBITDA margins (adjusted for one-time costs) were better than our...
Trivikram Consultants
526 Views
Share
bullish
•
Laurus Labs
•
11 Aug 2018 20:21
Laurus Labs - 1QFY19- One More Difficult Quarter Ahead, Strong Growth in FY20E
Laurus Labs reported 1QFY19 results on 3rd August 2018 and held a conference call on 4th August 2018. Revenues grew 9.7% YoY to Rs. 5,390 Mn,...
Trivikram Consultants
472 Views
Share
bullish
•
Laurus Labs
•
22 Jun 2018 20:06
Laurus Labs - Annual Report Review
According to Annual Report FY18, Laurus Labs (LAURUS IN) has strengthened its business with strong R&D, building capacities and expanding...
Trivikram Consultants
176 Views
Share
bullish
•
Laurus Labs
•
14 May 2018 20:29
Laurus Labs- 4QFY18 Result Update
Laurus Labs reported 4QFY18 results on 10th May 2018 and held a conference call on 11th May 2018.Performance Highlights Laurus reported Q4FY18...
Trivikram Consultants
145 Views
Share
First
Previous
7
8
9
10
11
12
13
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7
x